AbCellera (ABCL) has pivoted to in-house drug development, with two Phase 1 assets and a recent share price surge despite early-stage risks.

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...

Discover the fascinating world of creativity with our video, "Top 7 Homemade Inventions and Useful Ideas." Unleash your inner inventor as we explore innovative DIY projects that you can easily ...

New data centers and service centers designed to enhance infrastructure coverage and stay ahead of global growing demand for AI and Cloud services ...

Top‑50 global university deepens its North America and Europe collaborations to fast‑track drug discovery and health innovation. BOSTON & MELBOURNE, Australia--(BUSINESS WIRE)--Monash University, ...

Speakers Honorable Kimberly A. Lightford In January 2019, Kimberly A. Lightford made history when she became the firstBlack woman to serve as Illinois’ ...

Jon Ganz committed a terrible crime in his youth, but he survived prison, fell in love, and was starting over. His new life unraveled in a way that nobody could have predicted ...

President Yoweri Kaguta Museveni, the Presidential flagbearer for the ruling National Resistance Movement (NRM) in the 2026 general elections, concluded his second day of campaigning in the Lango ...

From an Emmy-winning writer of HBO’s Succession, this love-and-science thriller places audiences inside a clinical trial where two volunteers sign up to test a dopamine-regulating drug under ...

In the English countryside of the mid-1990s lies Stanton Wood, a reformatory for teenagers that represents the last chance for youths with behavioral ...

Black patients in need of organ transplants are facing increased barriers to accessing Medicaid due to the Trump administration's defunding and reshaping of assistance programs, which could lead to 16 ...

Luke Miels has been appointed CEO designate of GSK, the London-based pharmaceutical and biotechnology giant. He has been the company's chief commercial officer since 2017, and will succeed Emma ...